Results 231 to 240 of about 3,980,763 (249)

FastNano Liquid: An Automated Platform for Small‐Angle X‐ray Scattering‐Based Materials Discovery

Advanced Engineering Materials, EarlyView.
We present FastNano Liquid, an automated small‐ and wide‐angle X‐ray scattering platform for the combined synthesis and characterization of (nano)materials. The platform is coupled to varied reactor workflows for both in situ studies of reaction kinetics and ex situ screening of synthesis conditions to support machine learning‐guided exploration ...
Pierre‐Baptiste Flandrin, Émeline Cournède, Jens Krarup, Michael Lesa, Foyzul Hasan, Amandine Séné, Arnaud Lahouati, David Benhaiem, Jérémie‐Luc Sanchez, Simon Delacroix, Thierry Gacoin, Fabienne Testard, Damien Faivre, David Carriere, Corinne Chevallard, Olivier Taché, Mark A. Levenstein   +16 more
wiley   +1 more source

Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA). [PDF]

J Neurol
Chisari CG, Amato MP, Di Sapio A, Foschi M, Iaffaldano P, Inglese M, Fermo SL, Lugaresi A, Lus G, Mascoli N, Montepietra S, Pesci I, Quatrale R, Salemi G, Torri Clerici V, Totaro R, Valentino P, Filippi M, Patti F.   +18 more
europepmc   +1 more source

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. [PDF]

BMJ Open
Blackstone J, Williams T, Nicholas JM, Bordea E, De Angelis F, Bianchi A, Calvi A, Doshi A, John N, Apap Mangion S, Wade C, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson N, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri S, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Nixon SJ, Beveridge J, Hawton A, Tebbs S, Braisher M, Giovannoni G, Ciccarelli O, Greenwood J, Thompson AJ, Hunter R, Pavitt S, Pearson O, Evangelou N, Sharrack B, Galea I, Chandran S, Ford HL, Frost C, Chataway J.   +61 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis: Multicenter study in Argentina

Multiple Sclerosis Journal, 2021
Edgar Carnero Contentti, Ricardo Alonso, Edgardo Cristiano   +2 more
exaly  

Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS

Multiple Sclerosis Journal, 2022
Eva Strijbis, Pavle Repovic, Marcus W Koch   +2 more
exaly  

Defining secondary progressive multiple sclerosis.

Brain, 2016
Raed Alroughani, Thor Petersen, Alexandre Prat   +2 more
exaly  

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis

Multiple Sclerosis Journal, 2014
Ilana Katz Sand, Stephen Krieger, Colleen Farrell   +2 more
exaly  

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

Brain, 2000
Gareth J. Barker, Massimo Filippi, Tarek A Yousry   +2 more
exaly  

Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis

Multiple Sclerosis Journal, 2020
Emmanuelle Leray, Kévin Ahrweiller, Anne Kerbrat   +2 more
exaly  

Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.

Multiple Sclerosis Journal, 2011
In-Young Choi, S G Lynch
exaly